Sílvia Paredes1, Laura Ribeiro2. 1. Faculty of Medicine, University of Porto. 2. Department of Biochemistry and Center for Medical Education, Faculty of Medicine, University of Porto.
Abstract
OBJECTIVE: This article reviews the state of the art regarding the association between glucocorticoid actions and both obesity and insulin resistance, two main features of the metabolic syndrome. METHODS: A methodological assessment of the literature on PubMed and SciELO databases was conducted by using the following terms: stress, metabolic syndrome, glucocorticoids, obesity, insulin resistance, hypothalamic-pituitary-adrenal-axis and 11β-hydroxysteroid dehydrogenase. RESULTS: Chronic stress, mainly through hypothalamic-pituitary-adrenal axis dysregulation, promotes the accumulation of visceral fat. Reciprocally, obesity promotes a systemic low-grade inflammation state, mediated by increased adipokine secretion, which can chronically stimulate and disturb stress system. This vicious cycle, probably initiated by visceral adipose tissue dysfunction, might be the trigger for the development of metabolic syndrome. CONCLUSION: Given the strong evidences linking glucocorticoid release, obesity and type 2 diabetes, better understanding of the mechanisms underlying this connection might be useful for prevention and treatment of the metabolic syndrome.
OBJECTIVE: This article reviews the state of the art regarding the association between glucocorticoid actions and both obesity and insulin resistance, two main features of the metabolic syndrome. METHODS: A methodological assessment of the literature on PubMed and SciELO databases was conducted by using the following terms: stress, metabolic syndrome, glucocorticoids, obesity, insulin resistance, hypothalamic-pituitary-adrenal-axis and 11β-hydroxysteroid dehydrogenase. RESULTS: Chronic stress, mainly through hypothalamic-pituitary-adrenal axis dysregulation, promotes the accumulation of visceral fat. Reciprocally, obesity promotes a systemic low-grade inflammation state, mediated by increased adipokine secretion, which can chronically stimulate and disturb stress system. This vicious cycle, probably initiated by visceral adipose tissue dysfunction, might be the trigger for the development of metabolic syndrome. CONCLUSION: Given the strong evidences linking glucocorticoid release, obesity and type 2 diabetes, better understanding of the mechanisms underlying this connection might be useful for prevention and treatment of the metabolic syndrome.
Authors: Diana A Stavreva; Antoine Coulon; Songjoon Baek; Myong-Hee Sung; Sam John; Lenka Stixova; Martina Tesikova; Ofir Hakim; Tina Miranda; Mary Hawkins; John A Stamatoyannopoulos; Carson C Chow; Gordon L Hager Journal: Genome Res Date: 2015-02-12 Impact factor: 9.043
Authors: Judit Tenk; Péter Mátrai; Péter Hegyi; Ildikó Rostás; András Garami; Imre Szabó; Margit Solymár; Erika Pétervári; József Czimmer; Katalin Márta; Alexandra Mikó; Nóra Füredi; Andrea Párniczky; Csaba Zsiborás; Márta Balaskó Journal: PLoS One Date: 2016-11-21 Impact factor: 3.240
Authors: Mónica Patricia Cala; María Teresa Agulló-Ortuño; Elena Prieto-García; Carolina González-Riano; Lucía Parrilla-Rubio; Coral Barbas; Carmen Vanesa Díaz-García; Antonia García; Cristina Pernaut; Jorge Adeva; María Carmen Riesco; Francisco Javier Rupérez; Jose Antonio Lopez-Martin Journal: J Cachexia Sarcopenia Muscle Date: 2018-02-20 Impact factor: 12.910
Authors: Jonatan Dassonvalle; Francisco Díaz-Castro; Camila Donoso-Barraza; Carlos Sepúlveda; Francisco Pino-de la Fuente; Pamela Pino; Alejandra Espinosa; Mario Chiong; Miguel Llanos; Rodrigo Troncoso Journal: Int J Mol Sci Date: 2020-10-14 Impact factor: 5.923